β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study

Autor: Paakinaho A, Tiihonen M, Koskela H, Koponen M, Tiihonen J, Hartikainen S, Tolppanen AM

Publikováno v: Clinical Epidemiology, Vol Volume 15, Pp 695-705 (2023)

Anne Paakinaho,1 Miia Tiihonen,1 Heikki Koskela,2,3 Marjaana Koponen,1,4 Jari Tiihonen,5,6 Sirpa Hartikainen,1 Anna-Maija Tolppanen1 1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland; 2Unit for Medicine a

Externí odkaz: https://doaj.org/article/1b279a4f956143248a74868b4d61f5af

HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma.

Autor: Koskela H; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Li Y; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Joutsiniemi T; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Muranen T; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Isoviita VM; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Huhtinen K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland., Micoli G; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Lavikka K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Marchi G; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hietanen S; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hynninen J; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland. Electronic address: mijohy@utu.fi.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Jan; Vol. 180, pp. 91-98. Date of Electronic Publication: 2023 Dec 06.

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.

Autor: Pikkusaari S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tumiati M; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Li Y; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Perez-Villatoro F; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Muranen T; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Salko M; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Huhtinen K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kanerva A; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Koskela H; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland., Tapper J; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Koivisto-Korander R; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Joutsiniemi T; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland., Haltia UM; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Lassus H; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Färkkilä A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN digital precision cancer medicine flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Hynninen J; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland., Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland., Carpén O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Kauppi L; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN digital precision cancer medicine flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3110-3123.

Cross-country skiers often experience respiratory symptoms during and after exercise but have a low prevalence of prolonged cough.

Autor: Mäki-Heikkilä R; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Koskela H; Unit for Medicine and Clinical Research, Pulmonary Division, Kuopio University Hospital, Kuopio, Pohjois-Savo, Finland.; Institute of Clinical Sciences, Faculty of Health Sciences, University of Eastern Finland School of Medicine, Kuopio, Pohjois-Savo, Finland., Karjalainen J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Allergy Centre, Tampere University Hospital, Tampere, Pirkanmaa, Finland., Parkkari J; Tampere Research Center of Sports Medicine, UKK Institute, Tampere, Pirkanmaa, Finland.; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyvaskyla, Finland., Huhtala H; Faculty of Social Sciences, Tampere University, Tampere, Pirkanmaa, Finland., Valtonen M; Finnish Institute of High Performance Sport KIHU, Jyväskylä, Finland., Lehtimäki L; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Allergy Centre, Tampere University Hospital, Tampere, Pirkanmaa, Finland.

Publikováno v: BMJ open sport & exercise medicine [BMJ Open Sport Exerc Med] 2023 Jun 13; Vol. 9 (2), pp. e001502. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).

Hypertonic saline cough provocation test with salbutamol pre-treatment: evidence for sensorineural dysfunction in asthma.

Autor: Koskela, H. O.¹ heikki.koskela@kuh.fi, Purokivi, M. K.¹, Kontra, K. M.², Taivainen, A. H.¹, Tukiainen, H. O.¹

Publikováno v: Clinical & Experimental Allergy. Jul2008, Vol. 38 Issue 7, p1100-1107. 8p. 1 Chart, 4 Graphs.